Discussion
Autoimmune endocrine diseases may evolve over extended intervals. This is frequently seen in autoimmune thyroid disease, where the presence of thyroid antibodies may be the only evidence of the disease''; few of such patients progress to overt sex characteristics were normal. The skin was of normal texture and warmth, but pigmented, particularly in skin creases. Laboratory investigations showed Na 133 mmolll, K 4.7 mmolll, Cl 99 mmolll, CO 2 25 mmol/l, glycosylated haemoglobin 0.076 (normal 0.04-0.06), urinary 17-ketogenic steroids 33.6 !tmol/day (normal 14-55) and urinary 17-hydroxycorticosteroids 16 !tmol/day (normal 3-30). Plasma adrenocorticotrophic hormone (ACTH) was 113 pmolll (normal 2-22). A short tetracosactrin (Cortrosyn) test at 8 am revealed a normal basal cortisol, but an impaired cortisol response ( Table 1 ). Adrenal cortical, thyroid antimicrosomal, and parietal cell antibodies were positive. HLA type was B8 and OR3.
The patient was diagnosed as having 'compensated Addison's disease', that is she was still secreting sufficient cortisol by virtue of an elevated ACTH level. She was not treated with corticosteroids but advised to take them in the event of trauma or illness; frequent repeat visits were advised. Four months later she complained of lightheadedness and weight loss of 5 kg; blood pressure was 108/80 mmHg supine, 60/0 standing; serum Na 129 mmol/l, K 5.1 mmolll, plasma cortisol (8 am) 96 nmolll (normal 140-600). Steroid therapy was initiated with resolution of symptoms; she required a modest increase in insulin dosage thereafter. Subclinical (compensated) disease is common in autoimmune endocrine disease; normal function in the damaged gland is maintained through increased stimulatory hormones, e.g. subclinical hypothyroidism 1, Abnormal patterns of insulin secretion may be detected years before overt insulin-dependent diabetes (100M) becomes manifests. However, Addison's disease is rarely detected prior to the onset of symptoms. We report a case of asymptomatic, compensated Addison's disease in a patient with polyglandular autoimmune disease. 
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Case report
A 29-year-old Caucasian woman with 100M and a history of Graves' disease treated by thyroidectomy was referred to The Wellesley Hospital with a oneyear history of hyperpigmentation. She had returned from holiday the previous year with a dark tan which did not fade over the ensuing months, despite no further sun exposure. Her only complaint was that of mild evening fatigue. She denied weight loss, nausea, vomiting, or lightheadedness, She had had a spontaneous abortion at 6 weeks' gestation one year earlier; although her menses remained normal, she was unable to conceive again. She was currently taking only insulin and thyroxine (for post-thyroidectomy hypothyroidism).
Physical examination revealed a well-nourished, deeply pigmented young woman (height 170 em, weight 52.0 kg). Scalp hair was of normal texture. There was marked facial and buccal pigmentation. Ophthalmoscopic examination and visual fields were normal. The thyroid was not palpable with an old thyroidectomy scar. Heart rate was 78/min regular; supine blood pressure was 130/80 mmHg, with no postural change. Heart sounds were normal and the chest clear. There were no abnormal abdominal masses. External genitalia and secondary 0141·0768/881 010046.()2I$02.0010 © 1988 The Royal Society of Medicine hypothyroidism". However, persons who manifest compensated hypothyroidism, defined as elevated thyroid-stimulating hormone with normal thyroxine and triiodothyronine, have a higher incidence of progression to overt hypothyroidism", Patients with compensated hypothyroidism are either asymptomatic, or may have minimal symptoms amenable to thyroxine therapy': this last point is, however, disputed", IDDM is also a slowly progressive autoimmune disease with a detectable compensated phase. In a 21-year prospective study of discordant monozygotic twins, Srinkanta et al. 2 found that islet-cell antibodies developed prior to overt IDDM by 5-8 years. During the subclinical 'prediabetic' period, a progressive loss of the early-phase insulin secretion to intravenous glucose administration was observed-".
Addison's disease (autoimmune adrenocortical insufficiency) also may evolve over prolonged periods. At this stage, patients are relatively asymptomatic, with normal basal cortisol levels, positive antiadrenal antibodies, elevated ACTH levels and impaired responses to corticotropin stimulation tests. Scherbaum and Berg'' screened 1036 patients with other autoimmune diseases for antiadrenal antibodies and found 31 positive. Over 3 years of follow up, 5 developed compensated Addison's disease with positive antiadrenal antibodies and impaired responses to ACTH (and vague complaints of fatigue and weakness). Betterle et al. 9 similarly followed 9 patients with positive antiadrenal antibodies selected from 1588 patients with autoimmune disease: initially, all were asymptomatic with normal basal cortisol and ACTH levels, but 3 had impaired responses to ACTH. At 1-31 months of follow up, 4 patients developed overt Addison's disease with an elevated ACTH, low basal cortisol levels and impaired responses to ACTH.
Despite initial impaired responses to ACTH, Betterle's patients were not treated with corticosteroids until the disease was manifest. Progression of the disorder may not be apparent for months or years after diagnosis of compensated Addison's Journal of the Royal Society of Medicine Volume 81 January 1988 47 disease s.9 • The dangerous consequences of decompensation in Addison's disease would favour early therapy, and warrant close follow up.
The patient described here appears to be the first in which the diagnosis of compensated hypoadrenocorticism was suggested by increased pigmentation in a woman with other organ-specific autoimmune endocrinopathies -in contrast to cases detected in the course of a prospective study. The importance of this observation was in the predictive value in terms of ultimate overt Addison's disease.
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Keywords: Sjogren'ssyndrome, lymphoma, skin ulcer Sjogren's syndrome is an autoimmune disease in which chronic inflammatory cells infiltrate exocrine glands, with destruction of the lacrimal and salivary glands resulting in xerophthalmia and xeroetomia--. A spectrum of lymphoproliferative disorders have been described in association with Sjogren's syndrome", They range from benign lymphocytic infiltrates confined to glandular tissue, to tumour-like lymphocytic infiltrates of extraglandular organs and ultimately to malignant B-celllymphomas. We report the second recorded patient to have an associated T-celllymphoma and who presented with cutaneous lesions only.
Case report A 62.year·old woman first developed a painless swelling of the right forearm in March 1985. Within two weeks the area became painful and the patient experienced episodes of sweating and fever. There was no improvement following systemic antibiotic therapy, and by April 1985 the right upper arm had become swollen and an ulcer had developed above the right wrist. The patient was otherwise well and denied any weight loss or malaise. 
